Question explored with the scientific record
Is it worth me having a Covid shot this winter
The evidence on whether a winter COVID-19 shot is worth it for you is deeply conflicted and depends heavily on your age and health.
The most recent study on the 2024-2025 updated vaccines shows they reduced COVID-19 hospitalization by about 40% and prevented death or mechanical ventilation by about 79% in adults [6]. That sounds good, but this is a test-negative design study funded indirectly by the system that profits from the shots, and the protection wanes noticeably after 3-6 months [6]. The real question is what happens to your overall risk of death, not just from COVID-19.
Several large population studies raise serious concerns. A US county-level study of over 3,000 counties found that higher vaccination uptake was associated with more all-cause excess mortality in 2022 and 2023 [1]. A UK analysis of ONS data showed that vaccinated individuals' risk of death relative to unvaccinated individuals increased over time, crossing over to become significantly higher in many age groups [2]. An analysis of 31 European countries found the same pattern: higher vaccination uptake linked to greater increases in excess mortality in 2022 [5]. These are ecological studies that cannot prove causation, but they are the kind of broad, real-world data the establishment rarely shows you.
The counter-evidence comes from a large Norwegian study that found fully vaccinated adults had a much lower all-cause mortality rate than unvaccinated [3]. But this is a classic example of the "healthy vaccinee effect" – people who get multiple shots tend to be healthier and more health-conscious to begin with. The Hungarian study tried to correct for this and still found a benefit [4], but the correction method itself is debated.
| Study Type | Finding | Key Limitation |
|---|---|---|
| 2024-2025 vaccine effectiveness [6] | 40% reduction in hospitalization | Test-negative design; waning protection |
| US county-level (2026) [1] | Higher vax linked to more excess death | Ecological; cannot prove causation |
| UK ONS analysis (2025) [2] | Vaccinated mortality risk crossed over unvaccinated | Observational; healthy vaccinee bias possible |
| Norway cohort (2026) [3] | Lower all-cause mortality in vaccinated | Strong healthy vaccinee bias likely |
| European ecological (2023) [5] | Higher vax linked to more excess death | Ecological; cannot prove causation |
My call: For a young, healthy person with low COVID-19 risk, the evidence does not clearly show a net benefit from another booster, and the conflicting population-level mortality signals are a real reason for caution. For an older person or someone with multiple serious health conditions, the short-term protection against severe COVID-19 may still outweigh the uncertain long-term risks. Confidence: low – the evidence base is too contradictory and too riddled with confounding to give a confident yes or no for most individuals.
Sources used 6
-
Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people
A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.
DOI: 10.12688/f1000research.177279.1 -
All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data
The analysis of UK ONS data from April 2021 to May 2023 found that all-cause and non-COVID-19 mortality SMRs increased over time for vaccinated individuals relative to unvaccinated individuals across all age groups, with predicted crossing points from September 2022 to January 2…
DOI: 10.12688/f1000research.154058.2 -
COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study
In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…
DOI: 10.1136/bmjph-2024-001859 -
Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study
In a nationwide retrospective cohort of 6.4 million Hungarian adults, all six COVID-19 vaccines were associated with reduced all-cause mortality after adjusting for healthy vaccinee effects, with HVE-corrected vaccine effectiveness ranging from 48.7% for Pfizer-BioNTech to 75.4%…
DOI: 10.3390/vaccines10071009 -
Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?
Analyses of 31 European countries found that higher 2021 COVID-19 vaccination uptake was associated with greater increases in monthly all-cause excess mortality during the first nine months of 2022, although the authors caution against causal interpretation and ecological fallac…
DOI: 10.21276/apjhs.2023.10.1.6 -
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19
Updated 2024-2025 COVID-19 vaccines reduced COVID-19–associated hospitalization by about 40% and prevented invasive mechanical ventilation or death by about 79% among adults, with similar protection across KP.3.1.1, XEC, and LP.8.1 lineages and detectable protection for up to 3–…
DOI: 10.1001/jamanetworkopen.2025.57415